SILO
Silo Pharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.33
−4.90%Margins
Gross margin
-474.3%
EBITDA margin
-8473.3%
EBIT margin
-8250.5%
Net margin
-8269.5%
FCF margin
-6176.8%
-91.5%
Return on equity
-75.1%
Return on assets
-91.3%
Return on invested capital
0.01x
Asset turnover
-$3.3M
Cash from operations
$3.10
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026